1. Small KW, DeLuca WS, Rosenberg T, Silva-Garcia R, Udar N, Puech B, Garcia CA, Rice TA, Fishman GA, Héon E, Folk JC, Streb LM, Haas CM, Wiley AL, Scheetz TE, Fingert JH, Mullins RF, Tucker BA, Stone EM (2016) North Carolina macular dystrophy is caused by dysregulation of the retinal transcription factor PRDM13. Ophthalmol 123:9–18
2. Small KW, Sompele SV, Nuytemans K, Vincent A, Yuregir O, Ciloglu E, Sariyildiz C, Rosseel T, Avetisjan J, Udar N, Vance JM, Pericak-Vance MA, De Baere E, Shaya FS (2021) A novel duplication involving PRDM13 in a Turkish family supports its role in North Carolina macular dystrophy(NCMD/MCDR1). Mol Vis 27:518–527 3. Sompele SV, Small KW, Cicekdal MB, López V, D’haene E, Shaya F, Agemy S, Van der Snickt T, Dueñas A, Rosseel RT, Van Heetvelde M, Vergul S, Balikova I, Bergen AA, CJF B, De Zaeytijd J, Inglehearn CF, Kousal B, Leroy BP et al (2022) Multi-omics profiling, in vitro and in vivo enhancer assays dissect the cis-regulatory mechanisms underlying North Carolina macular dystrophy, a retinal enhanceropathy. Am J Human Genet 109:2029–2048. https://doi.org/10.1016/j.ajhg.2022.09.013
4. Small KW, Hermsen V, Gurney N, Fetkenhour CL, Bresnick G, Folk JC (1991) North Carolina macular dystrophy (NCMD) and central areolar pigment epithelial dystrophy (CAPED), one family, one disease. Arch Ophthalmol 110:515–518
5. Small KW, Mullen L, Yelchits S, Udar N, Kelsell R, Hunt D, Klein R, Garcia C, Gallardo G, Weber B, Puech B, Puech V, Saperstein D, Lim J, Haller J, Flaxel C, Kelsell R, Hunt D, Evans K et al (1999) North Carolina macular dystrophy (MCDR1) locus: a fine resolution genetic map and haplotype analysis. Mol Vis 5:999